MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1183/13993003.00800-2018

Медицинская библиотека · The European respiratory journal · 2019

Systematic and combined endosonographic staging of lung cancer (SCORE study).

Crombag Laurence M M, Dooms Christophe, Stigt Jos A, Tournoy Kurt G, Schuurbiers Olga C J, Ninaber Maarten K, Buikhuisen Wieneke A, Hashemi Sayed M S, Bonta Peter I, Korevaar Daniël A, Annema Jouke T

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Guidelines recommend endosonography for mediastinal nodal staging in patients with resectable nonsmall cell lung cancer (NSCLC). We hypothesise that a systematic endobronchial ultrasound (EBUS) evaluation combined with an oesophageal investigation using the same EBUS bronchoscope (EUS-B) improves mediastinal nodal staging versus the current practice of targeted positron emission tomography (PET)-computed tomography (CT)-guided EBUS staging alone.A prospective, multicentre, international study (NCT02014324) was conducted in consecutive patients with (suspected) resectable NSCLC. After PET-CT, patients underwent systematic EBUS and EUS-B. Node(s) suspicious on CT, PET, EBUS and/or EUS-B imaging and station 4R, 4L and 7 (short axis ≥8 mm) were sampled. For patients without N2/N3 disease determined on endosonography, surgical-pathological staging was the reference standard.229 patients were included in this study. The prevalence of N2/N3 disease was 103 out of 229 patients (45%). A PET-CT-guided targeted approach by EBUS identified 75 patients with N2/N3 disease (sensitivity 73%, 95% CI 63-81%; negative predictive value (NPV) 81%, 95% CI 74-87%). Four additional patients with N2/N3 disease were found by systematic EBUS (sensitivity 77%, 95% CI 67-84%; NPV 84%, 95% CI 76-89%) and five more by EUS-B (84 patients total; sensitivity 82%, 95% CI 72-88%; NPV 87%, 95% CI 80-91%). Additional clinical relevant staging information was obtained in 23 out of 229 patients (10%).Systematic EBUS followed by EUS-B increased sensitivity for the detection of N2/N3 disease by 9% compared to PET-CT-targeted EBUS alone.

Для цитирования: Crombag Laurence M M, Dooms Christophe, Stigt Jos A, Tournoy Kurt G, Schuurbiers Olga C J, Ninaber Maarten K, Buikhuisen Wieneke A, Hashemi Sayed M S, Bonta Peter I, Korevaar Daniël A, Annema Jouke T. Systematic and combined endosonographic staging of lung cancer (SCORE study).. The European respiratory journal. 2019. DOI: 10.1183/13993003.00800-2018.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.